Insider trading

Period: 120 months Stock: ANNX Plan: Discretionary × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

44 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

44 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

44 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

44 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
44 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
44 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

44 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
24 Sep 2026
Love Douglas PRESIDENT AND CEO
Bought
$99.83K 26,065 at 3.83
7.2%
First buy in 3+ yrs
28 May 2026
Satter Muneer A Director · indirect
Bought
$3.32M 613,497 at 5.41
6.3%
Largest buy in 3 yrs
2 Mar 2026
ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER
Sold at will
$32.00K 5,894 at 5.43
3.2%
Not planned
2 Mar 2026
Dananberg Jamie CHIEF MEDICAL OFFICER
Sold at will
$31.60K 5,820 at 5.43
4.5%
Not planned
2 Mar 2026
Yednock Ted EVP & CHIEF INNOVATION OFFICER
Sold at will
$30.17K 5,566 at 5.42
3.5%
Not planned
2 Mar 2026
Lew Jennifer EVP & CHIEF FINANCIAL OFFICER
Sold at will
$30.16K 5,565 at 5.42
3.2%
Not planned
2 Mar 2026
Overdorf Michael EVP & CHIEF BUSINESS OFFICER
Sold at will
$23.52K 4,339 at 5.42
2.3%
Not planned
18 Feb 2026
Yednock Ted EVP & CHIEF INNOVATION OFFICER
Sold at will
$40.15K 7,857 at 5.11
7.5%
Not planned
18 Feb 2026
Lew Jennifer EVP & CHIEF FINANCIAL OFFICER
Sold at will
$40.12K 7,851 at 5.11
6.5%
Not planned
18 Feb 2026
Overdorf Michael EVP & CHIEF BUSINESS OFFICER
Sold at will
$31.75K 6,225 at 5.10
4.8%
Not planned
18 Feb 2026
ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER
Sold at will
$26.98K 5,290 at 5.10
4.1%
Not planned
18 Feb 2026
Dananberg Jamie CHIEF MEDICAL OFFICER
Sold at will
$26.98K 5,290 at 5.10
6.7%
Not planned
1 Dec 2025
Choi Jung Director · indirect
Bought
$138.27K 33,000 at 4.19
opened
First buy on file
21 Nov 2025
Satter Muneer A Director · indirect
Bought
$1.81M 422,613 at 4.28
4.5%
20 Nov 2025
Satter Muneer A Director · indirect
Bought
$1.79M 400,000 at 4.48
4.5%
19 Nov 2025
Satter Muneer A Director · indirect
Bought
$1.97M 500,000 at 3.94
5.9%
18 Nov 2025
Satter Muneer A Director · indirect
Bought
$1.59M 500,000 at 3.18
6.3%
17 Nov 2025
Satter Muneer A Director · indirect
Bought
$1.50M 500,000 at 2.99
6.8%
14 Jul 2025
Lew Jennifer EVP & CHIEF FINANCIAL OFFICER
Sold at will
$2.88K 1,117 at 2.58
0.9%
Not planned
14 Jul 2025
Yednock Ted EVP & CHIEF INNOVATION OFFICER
Sold at will
$2.88K 1,116 at 2.58
1.1%
Not planned
14 Jul 2025
Overdorf Michael EVP & CHIEF BUSINESS OFFICER
Sold at will
$2.23K 853 at 2.61
0.6%
Not planned
18 Feb 2025
Yednock Ted EVP & CHIEF INNOVATION OFFICER
Sold at will
$24.28K 8,345 at 2.91
12.0%
Not planned
18 Feb 2025
Lew Jennifer EVP & CHIEF FINANCIAL OFFICER
Sold at will
$20.18K 6,912 at 2.92
8.2%
Not planned
18 Feb 2025
Overdorf Michael EVP & CHIEF BUSINESS OFFICER
Sold at will
$19.52K 6,618 at 2.95
7.1%
Not planned
18 Feb 2025
ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER
Sold at will
$16.38K 5,515 at 2.97
6.2%
Not planned
18 Feb 2025
Dananberg Jamie CHIEF MEDICAL OFFICER
Sold at will
$16.34K 5,521 at 2.96
14.2%
Not planned
13 Feb 2025
Love Douglas PRESIDENT AND CEO
Sold at will
$14.81K 5,021 at 2.95
1.4%
Not planned
13 Feb 2025
Yednock Ted EVP & CHIEF INNOVATION OFFICER
Sold at will
$5.33K 1,783 at 2.99
2.5%
Not planned
13 Feb 2025
Lew Jennifer EVP & CHIEF FINANCIAL OFFICER
Sold at will
$5.32K 1,786 at 2.98
2.1%
Not planned
13 Feb 2025
Overdorf Michael EVP & CHIEF BUSINESS OFFICER
Sold at will
$4.26K 1,425 at 2.99
1.5%
Not planned
15 Jul 2024
Yednock Ted EVP & CHIEF INNOVATION OFFICER
Sold at will
$6.66K 1,106 at 6.02
1.5%
Not planned
15 Jul 2024
Lew Jennifer EVP & CHIEF FINANCIAL OFFICER
Sold at will
$6.66K 1,104 at 6.03
1.3%
Not planned
15 Jul 2024
Overdorf Michael EVP & CHIEF BUSINESS OFFICER
Sold at will
$4.72K 784 at 6.02
0.8%
Not planned
20 Feb 2024
Yednock Ted EVP & CHIEF INNOVATION OFFICER
Sold at will
$14.35K 2,604 at 5.51
3.5%
Not planned
20 Feb 2024
Lew Jennifer EVP & CHIEF FINANCIAL OFFICER
Sold at will
$14.34K 2,593 at 5.53
3.1%
Not planned
20 Feb 2024
Overdorf Michael EVP & CHIEF BUSINESS OFFICER
Sold at will
$10.69K 1,951 at 5.48
2.2%
Not planned
12 Feb 2024
Love Douglas PRESIDENT AND CEO
Sold at will
$32.03K 5,782 at 5.54
2.9%
Not planned
12 Feb 2024
Yednock Ted EVP & CHIEF INNOVATION OFFICER
Sold at will
$10.03K 1,810 at 5.54
4.8%
Not planned
12 Feb 2024
Lew Jennifer EVP & CHIEF FINANCIAL OFFICER
Sold at will
$10.02K 1,809 at 5.54
3.8%
Not planned
12 Feb 2024
Overdorf Michael EVP & CHIEF BUSINESS OFFICER
Sold at will
$7.46K 1,349 at 5.53
2.7%
Not planned
26 Dec 2023
Satter Muneer A Director · indirect
Bought
$1.01M 350,000 at 2.88
5.0%
11 Jul 2023
Lew Jennifer EVP & Chief Financial Officer
Sold at will
$4.05K 1,057 at 3.84
2.2%
Not planned
11 Jul 2023
Overdorf Michael EVP & Chief Business Officer
Sold at will
$3.75K 978 at 3.84
2.1%
Not planned
25 May 2023
Bought
$639.72K 300,000 at 2.13
5.6%
First buy on file
Showing 1–44 of 44.